Import Clearance Requirements: CBSA Customs and MDEL Verification

1. Key takeaways

Devices entering Canada must simultaneously satisfy the customs declaration requirements of the Canada Border Services Agency (CBSA) and the device compliance requirements of Health Canada. The core verification points at import are: the importer holds a valid MDEL (under paragraph 44(3), the person who imports must ensure that the person it imports for holds an establishment licence) and the target device holds a valid MDL (Class II to IV).

• There are two independent verification lines at import: the entity line (importer’s MDEL) and the product line (device’s MDL).
• The word valid carries operational weight: a suspended or cancelled licence ends the right to sell and import immediately.
• Health care institutions and retailers are themselves exempt from the MDEL, but the persons they import from must hold one, so foreign suppliers to them still need a licence.
• MDEL holders have a duty to confirm that devices are licensed or authorised at the time of import or sale, and this should be documented.
• Customs paperwork should carry licence numbers and verification records so the compliance position is visible at the border.

2. Legal basis

The import-stage requirements draw on the Regulations, the guidance document and Health Canada’s public statements about unlicensed devices. The table below lists each source with the provisions and dates relevant to clearance.

Neither the CBSA side nor the Health Canada side can be satisfied in isolation: a shipment can clear customs paperwork and still be non-compliant as a device, or be a fully licensed device that arrives under an importer whose establishment licence is not valid, so both checks belong in the same pre-shipment routine.

3. Expert insights

Insight 1: there are two independent verification lines at import.

The first is the entity line: under paragraph 44(3), the person who imports must ensure that the person it imports for holds an establishment licence (MDEL). The second is the product line: Class II, III and IV devices must hold a valid MDL. Goods can only enter compliantly when both lines pass. Treating them as one check is the most common planning error, because the two verifications draw on different records, different databases and different parties, and a failure on either line independently stops the shipment from being compliant.

Insight 2: the word valid has operational significance at import.

The official Health Canada wording emphasises that a device may not be sold or imported without a valid MDL. Once a licence is suspended or cancelled, the right to sell and to import is interrupted at the same time. Verification before import should therefore be done in real time, not on the basis of historical records. A licence that was valid when the purchase order was signed does not carry the shipment if its status has changed by the time the goods reach the border, which is why the check belongs at the moment of import rather than earlier in the transaction.

Insight 3: the verification responsibility on the health care institution and retailer path is not lifted by their own exemption.

Under paragraph 44(2), health care institutions and retailers are themselves exempt from the MDEL, but the persons they import from must hold an MDEL. A foreign distributor supplying such customers directly must hold an MDEL itself; this requirement is retained under the new rules taking effect on December 14, 2026. The customer’s exemption creates no relief for the supplier, and the transaction pattern of direct supply to institutions should be handled as its own licensing scenario rather than folded into any general exemption analysis.

Insight 4: the MDEL holder’s duty to confirm devices are licensed is an action before import.

Under GUI-0016, MDEL holders are responsible for confirming that devices are licensed or authorised at the time of import or sale. That confirmation should take written form rather than remaining an oral judgement. A dated record of which licence was checked, in which database, at what moment, turns the duty from an assertion into evidence, and it is precisely the kind of record that resolves questions quickly when a shipment is queried downstream.

4. Practical recommendations

• Build a pre-import dual-verification checklist: the importer’s MDEL is valid and the target device’s MDL is valid.
• Use Health Canada’s MDEL list, which shows only valid MDELs, and MDALL for the verifications.
• Model the path of direct supply to health care institutions or retailers separately; the new exemption does not apply.
• Put the MDEL holder’s confirmation that devices are licensed in writing and keep the records.
• Review the supply-chain structure before December 14, 2026 and confirm the allocation of responsibilities once the new exemption applies.

5. Verification checklist

• □ The importer’s MDEL validity was verified before import (using the MDEL list)
• □ The MDL validity of Class II to IV devices was verified (using MDALL)
• □ The path of direct supply to health care institutions and retailers is modelled separately
• □ The MDEL holder’s confirmation that devices are licensed is documented and traceable
• □ The supply-chain structure was reviewed before December 14, 2026
• □ Licence numbers and verification records are included in the customs document package

Regulatory information verified as of October 28, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Canadian market. Our team manages Health Canada Medical Device Licence and MDEL applications, prepares risk-classified dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com